Figure 2: Plots for selection of number of component in PLS method for ternary mixture tenofovir alafenamide fumarate (TEN) (a), emtricitabine (EMT) (b), dolutegravir sodium (DOL) (c) and scree plot; for selection of component in PCR (d)
| Close | |
|
|
|
|
Figure 2: Plots for selection of number of component in PLS method for ternary mixture tenofovir alafenamide fumarate (TEN) (a), emtricitabine (EMT) (b), dolutegravir sodium (DOL) (c) and scree plot; for selection of component in PCR (d)
|
|